Private-Equity Firm EQT to Buy Press Ganey for $2.35 Billion
(Bloomberg) -- Press Ganey Holdings Inc., which helps health-care providers survey patients, agreed to be acquired by private equity firm EQT in a deal valued at about $2.35 billion.
EQT will pay $40.50 a share in cash, according to a statement Tuesday. The offer means a very small premium to Monday's closing price of $40.33 for Press Ganey, which is majority-owned by private-equity firm Vestar Capital Partners. Still, the price is 62 percent higher than Press Ganey's initial public offering price of $25 a share in May 2015.
Press Ganey helps hospitals and doctors measure patient satisfaction and the quality of the care they provide, and offers consulting to help health-care providers improve. Since the 2010 passage of the Affordable Care Act, known as Obamacare, the U.S. has been increasingly pushing health-care providers to improve care quality.
“A takeout at this level is surprising given the company's strong execution and the stock's 28 percent run,” David Larsen, an analyst at Leerink Partners, said in a note to investors. Press Ganey “is a high-quality company that has executed well since going public.”
As of June 30, Vestar Capital owned 30.34 million Press Ganey shares, or about 57 percent, according to SEC filings. The private-equity firm bought a majority interest in Press Ganey in January 2008.
Press Ganey traded above the offer price on Tuesday. The shares rose 1.9 percent to $41.10 at 11:29 a.m. in New York. The deal is subject to shareholder approval and other conditions, and the companies said they expect it to be completed in the fourth quarter of this year.
Barclays Plc and Goldman Sachs Group Inc. were Press Ganey's financial advisers, while Latham & Watkins LLP and Richards, Layton & Finger PA provided legal counsel. Bank of America Corp.'s Merrill Lynch and Simpson Thacher & Bartlett LLP advised EQT.
EQT's offer gives Press Ganey an enterprise value of $2.35 billion, according to the statement. The deal has an equity value of about $2.25 billion, including restricted stock, and includes about $100 million of net debt.
To contact the reporter on this story: Zachary Tracer in New York at ztracer1@bloomberg.net. To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Stephen West, John Lauerman
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets